An automated database case definition for serious bleeding related to oral anticoagulant use
- PMID: 21387461
- PMCID: PMC3365595
- DOI: 10.1002/pds.2109
An automated database case definition for serious bleeding related to oral anticoagulant use
Abstract
Purpose: Bleeding complications are a serious adverse effect of medications that prevent abnormal blood clotting. To facilitate epidemiologic investigations of bleeding complications, we developed and validated an automated database case definition for bleeding-related hospitalizations.
Methods: The case definition utilized information from an in-progress retrospective cohort study of warfarin-related bleeding in Tennessee Medicaid enrollees 30 years of age or older. It identified inpatient stays during the study period of January 1990 to December 2005 with diagnoses and/or procedures that indicated a current episode of bleeding. The definition was validated by medical record review for a sample of 236 hospitalizations.
Results: We reviewed 186 hospitalizations that had medical records with sufficient information for adjudication. Of these, 165 (89%, 95%CI: 83-92%) were clinically confirmed bleeding-related hospitalizations. An additional 19 hospitalizations (10%, 7-15%) were adjudicated as possibly bleeding-related. Of the 165 clinically confirmed bleeding-related hospitalizations, the automated database and clinical definitions had concordant anatomical sites (gastrointestinal, cerebral, genitourinary, other) for 163 (99%, 96-100%). For those hospitalizations with sufficient information to distinguish between upper/lower gastrointestinal bleeding, the concordance was 89% (76-96%) for upper gastrointestinal sites and 91% (77-97%) for lower gastrointestinal sites.
Conclusion: A case definition for bleeding-related hospitalizations suitable for automated databases had a positive predictive value of between 89% and 99% and could distinguish specific bleeding sites.
Copyright © 2011 John Wiley & Sons, Ltd.
Similar articles
-
Positive predictive value of a case definition for diabetes mellitus using automated administrative health data in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid study.BMC Med Res Methodol. 2012 Aug 24;12:128. doi: 10.1186/1471-2288-12-128. BMC Med Res Methodol. 2012. PMID: 22920280 Free PMC article.
-
Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.JAMA. 2018 Dec 4;320(21):2221-2230. doi: 10.1001/jama.2018.17242. JAMA. 2018. PMID: 30512099 Free PMC article.
-
Agreement between coding schemas used to identify bleeding-related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients.Clin Cardiol. 2018 Jan;41(1):119-125. doi: 10.1002/clc.22861. Epub 2018 Jan 23. Clin Cardiol. 2018. PMID: 29360144 Free PMC article.
-
Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.Am J Med. 1993 Sep;95(3):315-28. doi: 10.1016/0002-9343(93)90285-w. Am J Med. 1993. PMID: 8368229 Review.
-
Management of haemorrhagic complications associated with oral anticoagulant treatment.Expert Opin Drug Saf. 2002 Jul;1(2):129-36. doi: 10.1517/14740338.1.2.129. Expert Opin Drug Saf. 2002. PMID: 12904147 Review.
Cited by
-
Prospective Monitoring of New Drugs in Older Adults with and without Frailty: Near-Real-Time Assessment of Effectiveness and Safety of Oral Anticoagulants in Medicare Data.Drugs Aging. 2024 Sep;41(9):763-773. doi: 10.1007/s40266-024-01142-9. Epub 2024 Sep 11. Drugs Aging. 2024. PMID: 39259265
-
Ten-Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice.J Am Heart Assoc. 2024 Jul 2;13(13):e035708. doi: 10.1161/JAHA.124.035708. Epub 2024 Jun 27. J Am Heart Assoc. 2024. PMID: 38934887 Free PMC article.
-
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Cancer: A Target Trial Emulation from SEER-Medicare Database.Cardiovasc Drugs Ther. 2024 Jun 7. doi: 10.1007/s10557-024-07589-7. Online ahead of print. Cardiovasc Drugs Ther. 2024. PMID: 38847907
-
Bleeding risk from anticoagulant thromboprophylaxis in patients with multiple myeloma: a MarketScan analysis.Res Pract Thromb Haemost. 2024 Apr 24;8(4):102418. doi: 10.1016/j.rpth.2024.102418. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 38798793 Free PMC article.
-
Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation.J Clin Med. 2024 Apr 15;13(8):2277. doi: 10.3390/jcm13082277. J Clin Med. 2024. PMID: 38673550 Free PMC article.
References
-
- Singer DE. Overview of the randomized trials to prevent stroke in atrial fibrillation. Ann Epidemiol. 1993;3:563–567. - PubMed
-
- Beyth RJ, Landefeld CS. Anticoagulants in older patients. A safety perspective. Drugs and Aging. 1995;6:45–54. - PubMed
-
- Bhatt DL, Fox KAA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Eng J Med. 2006;354:1706–1717. - PubMed
-
- Eshaghian S, Kaul S, Amin S, Shah P, Diamond GA. Role of clopidogrel in managing atherothrombotic cardiovascular disease. Ann Intern Med. 2007;146:434–441. - PubMed
-
- Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001–2015. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
